Advertisement

Ads Placeholder
Loading...

AstraZeneca PLC

AZN•NYSE
Healthcare
Drug Manufacturers - General
$203.49
$2.76(1.37%)
U.S. Market opens in 4h 11m

AstraZeneca PLC (AZN) Stock Overview

Explore AstraZeneca PLC’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap157.7B
P/E Ratio15.42
EPS (TTM)$6.53
ROE0.23%
Fundamental Analysis

AI Price Forecasts

1 Month$190.57
3 Months$98.17
1 Year Target$94.29

AZN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of AstraZeneca PLC (AZN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 67.73, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $94.29.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.42 and a market capitalization of 157.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.37%
5-Day Change
6.61%
1-Month Change
0.86%
3-Month Change
11.39%
6-Month Change
19.34%
Year-to-Date (YTD) Change
11.39%
1-Year Change
34.90%
3-Year Change
47.99%
5-Year Change
103.49%
All-Time (Max) Change
1918.75%

Contact Information

https://www.astrazeneca.com
44 20 3749 5000
1 Francis Crick Avenue, Cambridge, NaN, CB2 0AA

Company Facts

943,000 Employees
IPO DateMay 12, 1993
CountryGB
Actively Trading

Frequently Asked Questions